BR112012002553A2 - formulações terapêuticas de protetor solar com vitamina d e métodos para seus usos - Google Patents
formulações terapêuticas de protetor solar com vitamina d e métodos para seus usosInfo
- Publication number
- BR112012002553A2 BR112012002553A2 BR112012002553A BR112012002553A BR112012002553A2 BR 112012002553 A2 BR112012002553 A2 BR 112012002553A2 BR 112012002553 A BR112012002553 A BR 112012002553A BR 112012002553 A BR112012002553 A BR 112012002553A BR 112012002553 A2 BR112012002553 A2 BR 112012002553A2
- Authority
- BR
- Brazil
- Prior art keywords
- sunscreen
- vitamin
- methods
- therapeutic formulations
- formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Transplantation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/535,660 US8470304B2 (en) | 2009-08-04 | 2009-08-04 | Therapeutic vitamin D sun-protecting formulations and methods for their use |
PCT/US2010/044319 WO2011017380A1 (en) | 2009-08-04 | 2010-08-03 | Therapeutic vitamin d sun-protecting formulations and methods for their use |
Publications (3)
Publication Number | Publication Date |
---|---|
BR112012002553A2 true BR112012002553A2 (pt) | 2017-06-13 |
BR112012002553A8 BR112012002553A8 (pt) | 2017-10-31 |
BR112012002553B1 BR112012002553B1 (pt) | 2018-05-08 |
Family
ID=43534981
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012002553A BR112012002553B1 (pt) | 2009-08-04 | 2010-08-03 | composição de proteção solar terapêutica e seus usos |
Country Status (8)
Country | Link |
---|---|
US (3) | US8470304B2 (pt) |
EP (1) | EP2461691A4 (pt) |
JP (2) | JP6189037B2 (pt) |
CN (1) | CN102695418A (pt) |
AU (1) | AU2010279524A1 (pt) |
BR (1) | BR112012002553B1 (pt) |
CA (1) | CA2807463C (pt) |
WO (1) | WO2011017380A1 (pt) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8470304B2 (en) | 2009-08-04 | 2013-06-25 | Avidas Pharmaceuticals Llc | Therapeutic vitamin D sun-protecting formulations and methods for their use |
US20110189114A1 (en) * | 2010-01-29 | 2011-08-04 | Nyangenya Maniga | minoxidil composition and non-aerosol, non-spray foam method of delivery therefor |
WO2012127037A2 (en) * | 2011-03-24 | 2012-09-27 | Leo Pharma A/S | A composition comprising lipid nanoparticles and a corticosteroid or vitamin d derivative |
CA2877102C (en) * | 2011-06-29 | 2020-06-30 | Avidas Pharmaceuticals Llc | Topical formulations including lipid microcapsule delivery vehicles and their uses |
US9383256B2 (en) * | 2013-12-19 | 2016-07-05 | Jie Lian | UV dosimetry system with sensor data correction |
US10695290B2 (en) | 2014-05-19 | 2020-06-30 | A. Ebbie Soroudi, M.D., M.S., A Professional Medical Corporation | Non-irritating, non-blurring, photostable ophthalmic sunscreen composition |
US10420963B2 (en) | 2014-05-19 | 2019-09-24 | A. Ebbie Soroudi, M.D., M.S., A Professional Medical Corporation | Non-irritating, non-blurring ophthalmic sunscreen |
WO2016077884A1 (en) * | 2014-11-18 | 2016-05-26 | Sndr Pty Ltd | Topical composition |
CN105566146A (zh) * | 2016-03-10 | 2016-05-11 | 济宁市化工研究院 | D-泛醇三乙酸酯的制备方法 |
BR102016005675B8 (pt) * | 2016-03-15 | 2021-04-13 | Andre Moreira Castilho | produto de proteção solar e processo de aplicação de produto de proteção solar à pele |
CN109803725A (zh) * | 2016-07-12 | 2019-05-24 | A·埃比·索劳迪专业医疗公司 | 无刺激性、不致模糊、光稳定的眼用防晒组合物 |
EP3484480B1 (en) * | 2016-07-15 | 2021-09-22 | Wisconsin Alumni Research Foundation | The use of homosalate and octyl salicylate to treat multiple sclerosis |
DE102017127865A1 (de) * | 2017-11-24 | 2019-05-29 | Deutsches Zentrum Für Neurodegenerative Erkrankungen E. V. (Dzne) | Verbindung zur Anwendung bei der Steigerung von mentaler Leistungsfähigkeit |
CN108938606B (zh) * | 2018-09-05 | 2019-09-17 | 暨南大学 | 阿伏苯宗在制备抗肿瘤药物中的应用 |
KR102173192B1 (ko) * | 2020-03-11 | 2020-11-03 | 이정음 | 내구성이 향상된 패치 제조방법 |
KR20230123915A (ko) * | 2020-12-22 | 2023-08-24 | 라이온 가부시키가이샤 | 항염증제 |
US11975010B2 (en) * | 2021-01-13 | 2024-05-07 | The Daily Suncare, LLC | Compositions for facilitating topical administration of vitamin D while protecting against UV light |
GB202202031D0 (en) * | 2022-02-16 | 2022-03-30 | Dr Weller Ltd | Compositions for Vitamin D production |
Family Cites Families (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1404583A (en) * | 1971-10-08 | 1975-09-03 | Vymatt Sa | Urea compositions and methods of preparation thereof |
US4335120A (en) * | 1979-03-21 | 1982-06-15 | Hoffmann-La Roche Inc. | Administration of biologically active vitamin D3 and vitamin D2 materials |
US4230701A (en) * | 1979-03-21 | 1980-10-28 | Hoffmann-La Roche Inc. | Administration of biologically active vitamin D3 and vitamin D2 materials |
US4310511A (en) * | 1980-10-02 | 1982-01-12 | Massachusetts General Hospital | Sunscreen compositions containing Δ5,7 steroidal dienes |
USRE33107E (en) * | 1983-03-22 | 1989-11-07 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same |
US4946671A (en) * | 1987-10-22 | 1990-08-07 | The Procter & Gamble Company | Photoprotection compositions comprising sorbohydroxamic acid and an anti-inflammatory agent |
US4954332A (en) * | 1987-10-22 | 1990-09-04 | The Procter & Gamble Company | Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent |
US4847071A (en) * | 1987-10-22 | 1989-07-11 | The Procter & Gamble Company | Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent |
US5039513A (en) * | 1987-10-22 | 1991-08-13 | The Procter & Gamble Company | Photoprotection compositions and methods comprising sorbohydroxamic acid |
US4847069A (en) * | 1987-10-22 | 1989-07-11 | The Procter & Gamble Company | Photoprotection compositions comprising sorbohydroxamic acid and an anti-inflammatory agent |
US4847072A (en) * | 1987-10-22 | 1989-07-11 | The Procter & Gamble Company | Photoprotection compositions comprising tocopherol sorbate |
US4869897A (en) * | 1987-10-22 | 1989-09-26 | The Procter & Gamble Company | Photoprotection compositions comprising sorbohydroxamic acid |
ATE176396T1 (de) * | 1987-10-22 | 1999-02-15 | Procter & Gamble | Chelatbildner enthaltende lichtschutzmittel |
US5039516A (en) * | 1988-08-24 | 1991-08-13 | Dento-Med Industries, Inc. | Sunscreen preparation |
EP0419711B1 (de) * | 1989-09-28 | 1994-01-26 | Siemens Aktiengesellschaft | Schnittstellenbaustein zur Ankopplung modulierter Signale |
JPH05508655A (ja) * | 1990-06-21 | 1993-12-02 | トラスティーズ・オブ・ボストン・ユニバーシティー | ビタミンd前駆体からなる組成物、それらの類似体およびそれらの用途 |
US5194248A (en) * | 1990-06-21 | 1993-03-16 | Trustees Of Boston University | Compositions comprising vitamin D analog precursors and the use thereof |
US5167953A (en) * | 1990-06-21 | 1992-12-01 | Trustees Of Boston University | Compositions comprising tachysteral and the use thereof to provide vitamin D |
US5395829A (en) * | 1990-10-04 | 1995-03-07 | Trustees Of Boston University | Compositions comprising vitamin D lumisterol analog precursors |
US5207998A (en) | 1991-05-07 | 1993-05-04 | Richardson-Vicks Inc. | Suncare compositions |
JPH05246835A (ja) * | 1992-03-03 | 1993-09-24 | Shiseido Co Ltd | 皮膚外用剤 |
CA2122431C (en) | 1994-04-28 | 2006-10-10 | Reinhold W. Vieth | Topical administration of vitamin d to mammals and compositions therefor |
US5629021A (en) | 1995-01-31 | 1997-05-13 | Novavax, Inc. | Micellar nanoparticles |
US6242434B1 (en) * | 1997-08-08 | 2001-06-05 | Bone Care International, Inc. | 24-hydroxyvitamin D, analogs and uses thereof |
US5700451A (en) * | 1995-05-24 | 1997-12-23 | The Procter & Gamble Company | Sunscreen composition |
JP3542665B2 (ja) * | 1995-07-07 | 2004-07-14 | 株式会社資生堂 | 抗老化皮膚外用剤、コラーゲン架橋阻害皮膚外用剤及び抗紫外線皮膚外用剤 |
US5952317A (en) * | 1995-09-21 | 1999-09-14 | Wisconsin Alumni Research Foundation | Calcitriol derivatives and their uses |
US5728371A (en) * | 1996-04-29 | 1998-03-17 | L'oreal, S.A. | Skin protection, fragrance enhancing and vitamin delivery composition |
US5728372A (en) * | 1996-04-29 | 1998-03-17 | L'oreal, S.A. | Skin protection, fragrance enhancing and vitamin delivery composition |
US5662957A (en) | 1996-05-03 | 1997-09-02 | Novavax, Inc. | Oil containing lipid vesicles with marine applications |
US5811414A (en) * | 1997-05-16 | 1998-09-22 | Hoffmann-La Roche Inc. | Vitamin D3 analogs useful for reversing the photodamage in sun-exposed skin |
US6599513B2 (en) * | 1997-05-27 | 2003-07-29 | Sembiosys Genetics Inc. | Products for topical applications comprising oil bodies |
US6958148B1 (en) | 1998-01-20 | 2005-10-25 | Pericor Science, Inc. | Linkage of agents to body tissue using microparticles and transglutaminase |
HU226610B1 (en) | 1998-03-04 | 2009-04-28 | Teijin Ltd | Activated vitamin d3 emulsion-type lotions |
AU762481C (en) * | 1998-03-27 | 2004-08-19 | Oregon Health Sciences University | Vitamin D and its analogs in the treatment of tumors and other hyperproliferative disorders |
US6284234B1 (en) | 1998-08-04 | 2001-09-04 | Johnson & Johnson Consumer Companies, Inc. | Topical delivery systems for active agents |
US6217852B1 (en) * | 1998-08-15 | 2001-04-17 | Skinnovative Dermatologic Concepts, L.L.C. | Personal cleansing compositions having photoprotective agents |
US5972316A (en) * | 1998-10-16 | 1999-10-26 | The Procter & Gamble Company | UV protection compositions |
US5968485A (en) * | 1998-10-16 | 1999-10-19 | The Procter & Gamble Company | UV protection compositions |
US5976513A (en) * | 1998-10-16 | 1999-11-02 | The Procter & Gamble Company | UV protection compositions |
FR2785284B1 (fr) * | 1998-11-02 | 2000-12-01 | Galderma Res & Dev | Analogues de la vitamine d |
US7374779B2 (en) | 1999-02-26 | 2008-05-20 | Lipocine, Inc. | Pharmaceutical formulations and systems for improved absorption and multistage release of active agents |
JP4105819B2 (ja) * | 1999-04-26 | 2008-06-25 | 株式会社ルネサステクノロジ | 記憶装置およびメモリカード |
US6720001B2 (en) * | 1999-10-18 | 2004-04-13 | Lipocine, Inc. | Emulsion compositions for polyfunctional active ingredients |
FR2801305B1 (fr) * | 1999-11-24 | 2002-12-06 | Galderma Res & Dev | Analogues de la vitamine d |
FR2801307B1 (fr) * | 1999-11-24 | 2002-12-06 | Galderma Res & Dev | Analogues de la vitamine d |
AU4724401A (en) | 2000-02-28 | 2001-09-12 | Genesegues Inc | Nanocapsule encapsulation system and method |
GB0015617D0 (en) * | 2000-06-26 | 2000-08-16 | Vectura Ltd | Improved preparations for dermal delivery of active substances |
AU2452302A (en) | 2000-07-21 | 2002-02-05 | Mark B Lyles | Sunscreen formulations containing nucleic acids |
US7198801B2 (en) | 2000-08-03 | 2007-04-03 | Antares Pharma Ipl Ag | Formulations for transdermal or transmucosal application |
WO2002011768A1 (en) | 2000-08-03 | 2002-02-14 | Antares Pharma Ipl Ag | Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels |
FR2825087B1 (fr) * | 2001-05-22 | 2005-01-14 | Galderma Res & Dev | Analogues de la vitamine d |
CA2448065A1 (en) * | 2001-05-30 | 2002-12-05 | The Procter & Gamble Company | Topical cosmetic composition comprising an alpha-beta-unsaturated ester as bonding agent |
WO2003011238A2 (en) * | 2001-07-31 | 2003-02-13 | Merck Patent Gmbh | Sunscreen composition |
US7264795B2 (en) * | 2001-07-31 | 2007-09-04 | Merck Patent Gesellschaft | Sunscreen composition |
US6878693B2 (en) | 2001-09-28 | 2005-04-12 | Solubest Ltd. | Hydrophilic complexes of lipophilic materials and an apparatus and method for their production |
US7025952B1 (en) * | 2005-01-31 | 2006-04-11 | Aquea Scientific Corporation | Methods of preparation and use of bodywashes containing additives |
US6440402B1 (en) * | 2001-12-14 | 2002-08-27 | Avon Products, Inc. | Photostable sunscreen compositions and methods of stabilizing |
CA2429387A1 (en) * | 2002-05-22 | 2003-11-22 | Michael F. Holick | Compositions for providing vitamin d year round and uses thereof |
DE10232595A1 (de) * | 2002-07-18 | 2004-02-05 | Merck Patent Gmbh | Lichtschutzmittel |
US20040122105A1 (en) * | 2002-09-20 | 2004-06-24 | Griscom Bettle | Transdermal compositions |
US20040126339A1 (en) * | 2002-12-31 | 2004-07-01 | Roszell James A. | Sunscreen composition and methods for manufacturing and using a sunscreen composition |
US20040146539A1 (en) * | 2003-01-24 | 2004-07-29 | Gupta Shyam K. | Topical Nutraceutical Compositions with Selective Body Slimming and Tone Firming Antiaging Benefits |
US7425340B2 (en) | 2004-05-07 | 2008-09-16 | Antares Pharma Ipl Ag | Permeation enhancing compositions for anticholinergic agents |
US20060034779A1 (en) * | 2004-08-02 | 2006-02-16 | Agis Industries (1983) Ltd. | Foamable compositions containing vitamin D3 analogues, processes for preparing same and methods of treatment utilizng same |
WO2006035417A2 (en) | 2004-09-27 | 2006-04-06 | Sigmoid Biotechnologies Limited | Dihydropyrimidine microcapsule - formulations |
US20060073107A1 (en) * | 2004-10-04 | 2006-04-06 | Person John R | Use of vitamin D3 (cholecalciferol) in sunscreens |
US20060105069A1 (en) * | 2004-11-16 | 2006-05-18 | Alex Moffett | Pharmaceutical and therapeutic compositions derived from Garcinia mangostana L plant |
US20060110415A1 (en) * | 2004-11-22 | 2006-05-25 | Bioderm Research | Topical Delivery System for Cosmetic and Pharmaceutical Agents |
US20060141014A1 (en) * | 2004-12-28 | 2006-06-29 | Eknoian Michael W | Skin treatment articles and methods |
US7001592B1 (en) * | 2005-01-31 | 2006-02-21 | Aquea Scientific Corporation | Sunscreen compositions and methods of use |
US7115287B2 (en) * | 2005-03-03 | 2006-10-03 | F.L.M., L.L.C. | Topical medicament and method of use |
US20080112904A1 (en) * | 2005-03-08 | 2008-05-15 | Daniel Henry Traynor | Sunscreen Compositions And Methods Of Use |
US7371738B2 (en) | 2005-04-15 | 2008-05-13 | University Of South Florida | Method of transdermal drug delivery using hyaluronic acid nanoparticles |
WO2006116567A2 (en) * | 2005-04-26 | 2006-11-02 | Board Of Regents, The University Of Texas System | Tunable sunblock agents |
US7547434B2 (en) * | 2005-09-09 | 2009-06-16 | Johnson & Johnson Consumer Companies, Inc. | Compositions and methods for mitigating skin irritation |
EP1837053A1 (en) * | 2006-03-22 | 2007-09-26 | The Procter and Gamble Company | Cosmetic composition comprising gingko biloba and sunscreen agents |
US20070274932A1 (en) * | 2006-05-15 | 2007-11-29 | The Procter & Gamble Company | Water in oil emulsion compositions containing sunscreen actives and siloxane elastomers |
US20070297996A1 (en) * | 2006-06-22 | 2007-12-27 | The Procter & Gamble Company | Multi-phase composition comprising a sunscreen |
EP2317984B1 (en) | 2008-07-18 | 2018-10-31 | Biomod Concepts Inc. | Articles of manufacture releasing an active ingredient |
US8470304B2 (en) | 2009-08-04 | 2013-06-25 | Avidas Pharmaceuticals Llc | Therapeutic vitamin D sun-protecting formulations and methods for their use |
CA2877102C (en) | 2011-06-29 | 2020-06-30 | Avidas Pharmaceuticals Llc | Topical formulations including lipid microcapsule delivery vehicles and their uses |
-
2009
- 2009-08-04 US US12/535,660 patent/US8470304B2/en active Active
-
2010
- 2010-08-03 EP EP10807065.7A patent/EP2461691A4/en not_active Withdrawn
- 2010-08-03 BR BR112012002553A patent/BR112012002553B1/pt active IP Right Grant
- 2010-08-03 AU AU2010279524A patent/AU2010279524A1/en not_active Abandoned
- 2010-08-03 CN CN2010800450183A patent/CN102695418A/zh active Pending
- 2010-08-03 JP JP2012523720A patent/JP6189037B2/ja not_active Expired - Fee Related
- 2010-08-03 CA CA2807463A patent/CA2807463C/en active Active
- 2010-08-03 WO PCT/US2010/044319 patent/WO2011017380A1/en active Application Filing
-
2013
- 2013-05-13 US US13/892,831 patent/US8709387B2/en active Active
-
2014
- 2014-03-21 US US14/222,222 patent/US20150050226A1/en not_active Abandoned
-
2015
- 2015-10-02 JP JP2015197059A patent/JP2016041707A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP6189037B2 (ja) | 2017-08-30 |
JP2016041707A (ja) | 2016-03-31 |
AU2010279524A1 (en) | 2012-03-29 |
BR112012002553A8 (pt) | 2017-10-31 |
US8709387B2 (en) | 2014-04-29 |
CA2807463C (en) | 2018-07-10 |
EP2461691A1 (en) | 2012-06-13 |
EP2461691A4 (en) | 2014-08-13 |
US20110033399A1 (en) | 2011-02-10 |
WO2011017380A1 (en) | 2011-02-10 |
US20150050226A1 (en) | 2015-02-19 |
US20130344014A1 (en) | 2013-12-26 |
CN102695418A (zh) | 2012-09-26 |
US8470304B2 (en) | 2013-06-25 |
CA2807463A1 (en) | 2011-02-10 |
BR112012002553B1 (pt) | 2018-05-08 |
JP2013501067A (ja) | 2013-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012002553A2 (pt) | formulações terapêuticas de protetor solar com vitamina d e métodos para seus usos | |
BRPI0909185A2 (pt) | Derivado de vitamina e e seus usos | |
BR112012000660A2 (pt) | compostos heterociclos e seus usos | |
BRPI1010540A2 (pt) | "anticorpos especéficos para dkk-1 e seus usos" | |
BR112012009921A2 (pt) | métodos para reprogramar células e usos do mesmos | |
BRPI1011404A2 (pt) | mutantes e usos dos mesmos | |
BR112013006272A2 (pt) | compostos de piridina e seus usos | |
BRPI1013432A2 (pt) | derivado de indolizina e uso do mesmo para propósitos médicos | |
BR112013012190A2 (pt) | composições adesivas e seus usos | |
BR112012003262A8 (pt) | compostos de hidrazona heterocíclica e seus usos para tratar câncer e inflamação | |
BR112015004817A2 (pt) | bioconjugados compreendendo antígenos modificados e seus usos | |
BR112012004970A2 (pt) | inibidores de jak2 e seu uso para o tratamento de doenças mieloproliferativas e câncer | |
BRPI0911656A2 (pt) | formulações de nanopartículas e usos das mesmas | |
BR112012004802A2 (pt) | polipeptídeos tendo atividade oxirredutase e seus usos | |
BR112013023743A2 (pt) | anticorpo de fator de tecidos humanos e usos do mesmo | |
BR112013012129A2 (pt) | composições de adesivos e seus usos | |
BRPI0908175A2 (pt) | derivados de polimixina e composição farmacêuticas contendo os derivados de polimixina seus usos e métodos de preparação | |
BR112012000370A2 (pt) | derivados de 1,2,4-tiazolidin-3-ona e seus usos no tratamento de câncer | |
HK1187345A1 (en) | Derivatives of heteroarylsulfonamides, their preparation and their application in human therapy | |
CO7000778A2 (es) | Derivados de pirazolopiridina, su procedimiento de preparación y su uso terapéutico | |
BR112013011845A2 (pt) | produto para cuidado oral e métodos de uso e fabricação do mesmo | |
BR112013008898A2 (pt) | benzamidas substituídas e seus usos | |
BR112013011562A2 (pt) | produto para cuidado oral e métodos de uso e fabricação do mesmo | |
BRPI1016067A2 (pt) | ésteres e seus usos. | |
HK1176936A1 (en) | Arylsulfonamide pyridine-pyridinone derivatives, preparation of same, and therapeutic use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Ipc: A61K 8/67 (2006.01), A61Q 17/04 (2006.01) |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |